# XERIS PHARMACEUTICALS INC: Form D filings

XERIS PHARMACEUTICALS INC, a pharmaceuticals company in Chicago, IL, filed 10 Form D notices with the SEC between 2011 and 2017. The latest, on May 22, 2017, reports $30.1 million sold of a $45 million offering to 22 investors.

Find out what XERIS PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20XERIS%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=XERIS%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fxeris-pharmaceuticals-inc-1346302)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20XERIS%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=XERIS%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fxeris-pharmaceuticals-inc-1346302)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Illinois](https://specstream.ai/data/form-d/state/illinois): 1,511 rows, by operating companies, filed since November 1, 2024, $75.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/illinois
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 180 North LaSalle Street, STE 1800, Chicago, IL, 60601
- Phone: (512) 498-2670
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1346302

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 22, 2017 | New notice | $44,999,999 | $30,050,443 | $14,949,556 | 22 | May 17, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630217000002/0001346302-17-000002-index.htm) |
| Dec 30, 2016 | Amendment | $49,999,995 | $45,005,982 | $4,994,013 | 48 | Dec 31, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630216000002/0001346302-16-000002-index.htm) |
| Jan 11, 2016 | New notice | $49,999,995 | $41,005,980 | $8,994,015 | 47 | Dec 31, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630216000001/0001346302-16-000001-index.htm) |
| Sep 29, 2014 | New notice | $14,874,990 | $7,274,592 | $7,600,398 | 56 | Sep 17, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630214000001/0001346302-14-000001-index.htm) |
| Jul 10, 2013 | Amendment | $3,000,000 | $2,315,000 | $685,000 | 38 | May 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630213000002/0001346302-13-000002-index.htm) |
| Feb 14, 2013 | Amendment | $3,000,000 | $1,750,000 | $1,250,000 | 28 | May 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630213000001/0001346302-13-000001-index.htm) |
| Sep 25, 2012 | Amendment | $3,000,000 | $1,125,000 | $1,875,000 | 20 | May 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630212000002/0001346302-12-000002-index.htm) |
| Jun 8, 2012 | New notice | $3,000,000 | $225,000 | $2,775,000 | 6 | May 25, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630212000001/0001346302-12-000001-index.htm) |
| Oct 12, 2011 | Amendment | $1,958,748 | $1,837,848 | $120,900 | 19 | Jul 5, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630211000006/0001346302-11-000006-index.htm) |
| Jul 19, 2011 | New notice | $1,958,748 | $1,298,748 | $660,000 | 17 | Jul 5, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1346302/000134630211000005/0001346302-11-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Paul Edick | Executive Officer, Director |  |
| Cary McNair | Director |  |
| John Shannon | Executive Officer |  |
| Robert Faulker | Director |  |
| Navneet Puri | Director |  |
| Brad Huckabee | Executive Officer |  |
| Jonathan Rigby | Director |  |

[Every Form D from the week of May 22, 2017](https://specstream.ai/data/form-d/week/2017-05-22) · [All recent filings in Illinois](https://specstream.ai/data/form-d/state/illinois) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what XERIS PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).